Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This is an open-label, uncontrolled, multicenter phase II clinical trial. The purpose of this
study is to evaluate acute toxicity and efficacy of cisplatin and 5-Fu combined with
nimotuzumab in patients with untreated metastatic nasopharyngeal carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Affiliated Cancer Hospital of Shantou University Medical College Cancer Hospital of Shantou University First People's Hospital of Foshan Fujian Cancer Hospital Guangxi Medical University Guangzhou Medical University Hangzhou Cancer Hospital Hubei Cancer Hospital Hunan Provincial Cancer Hospital Jiangxi Provincial Cancer Hospital People's Hospital of Guangxi Tongji Hospital Wuhan Union Hospital, China Wuhan University Zhejiang Cancer Hospital